We bring a new perspective to pre-seed & seed healthcare investing.
Founder & General Partner
Roberto has spent the majority of his career funding category-defining healthcare entrepreneurs, beginning with SVB in Palo Alto where he provided venture debt to over 50 venture-backed companies. Roberto also helped with the launch of L’Attitude Ventures, a $101M venture fund focused on backing U.S. Latino entrepreneurs. Roberto counts on extensive technical due diligence experience through his tenure at the $30M George Schultz Innovation Fund at the University of Chicago and at Health Innovation Capital, a pediatrics-focused healthcare firm.
Raised in Tecate, Mexico, Roberto is an avid mentor to first-generation students and undocumented youth. He is the youngest of seven and the first in his family to attend college after growing up undocumented. Roberto serves on the Board of Directors for Pro Kids Golf Academy / The First Tee of San Diego.
Roberto graduated from Columbia University with degrees in Economics and Hispanic Studies and received an MBA from the University of Chicago’s Booth School of Business.
Dr. Arlene Ruiz de Luzuriaga, MPH, MBA is an Assistant Professor of Medicine in the Section of Dermatology, and Vice-Chief for Dermatopathology Operations at the University of Chicago.
Arlene specializes in epidemiologic studies in dermatology and dermatopathology, clinical informatics, and the use of information technology for the improvement of patient care, diagnosis and treatment algorithms, quality improvement, and medical education. Her passion for venture capital and scaling impact through technology stems from her commitment to her patients.
Dr. Ruiz de Luzuriaga holds an MPH from the University of North Carolina at Chapel Hill and an MBA with honors from the University of Chicago, where she received the Vashee Promising Entrepreneur Award from the Polsky Center for Entrepreneurship and Innovation in 2017. She is a graduate of Duke University School of Medicine and received her BA from Northwestern University.
Dr. Ramirez-Peña is currently a fellow in the Division of Cancer Prevention Breast and Gynecologic Cancer research group. She is also apart of the Division of Cancer Control and Population Science. Her research interests include breast cancer chemoprevention, clinical trials, cancer registry operations, recurrence, and health disparities.
Dr. Ramirez-Peña’s doctoral research investigated the metabolic changes that metastatic breast cancer cells undergo following the epithelial to mesenchymal transition. She also explored combination therapeutic strategies to simultaneously target cancer stem cells and differentiated cancer cells in breast tumors. After her Ph.D., Dr. Ramirez-Peña became a Cancer Prevention Fellow at the National Cancer Institute. As part of her MPH, she worked on health disparities research and analyzed Maryland state and national cancer registry data to evaluate the risks in African American women for being diagnosed with advanced stage breast cancer before and after the implementation of the Affordable Care Act.
Dr. Ramirez-Peña received her Ph.D. from The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences and completed a Master of Public Health degree at the Johns Hopkins Bloomberg School of Public Health.